Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Find out what constitutes a good retirement savings strategy. Maximize your contributions and ensure a financially stable retirement.
19,472 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A federal case in Western Missouri pits 15 borrowers against Veterans United over alleged kickbacks and steering tied...
Ark Invest's Cathie Wood is signaling a bold stance by scooping up Coinbase and Circle during a crypto sell-off. This...
The idea that skilled trades could become high earners is reshaping how investors view AI-driven growth. This piece c...
When new Berkshire leadership takes the reins, investors wonder which names could ride along. Here’s why a flavor-foc...
Johnson & Johnson and Coca-Cola posted strong Q1 2026 results as markets rotate toward defensive plays. The big quest...
New research finds america pays workers just a fraction of the country’s wealth, a share that trails most OECD peers ...
U.S. stocks faced a bifurcated session as analysts issued fresh price targets and ratings on key names, signaling the...
A surprise drop in June inflation is pushing investors to question a July rate hike. Analysts say the july rate hike ...
A misdirected public-comment inbox is stirring confusion over the SEC's plan to scrap quarterly reporting. Officials ...
As Ford grows its electric lineup, investors weigh profitability, supply chains, and policy risk. The debate over for...
Dell shares tumbled about 14% as investors pulled back from AI hardware names, with HPE and Super Micro also sliding....